| Title | Author(s) | Year | View Count |
 | First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: Safety and efficacy in an open-label study in 2251 patients | Smith, IE; Pierga, JY; Biganzoli, L; CortésFunes, H; Thomssen, C; Pivot, X; Fabi, A; Xu, B; Stroyakovskiy, D; Franke, FA; Kaufman, B; Mainwaring, P; Pienkowski, T; de Valk, B; Kwong, A; GonzálezTrujillo, JL; Koza, I; Petrakova, K; Pereira, D; Pritchard, KI | 2011 | 123 |
|
